Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer
Clinical trial NCT04003246 · COMPLETED
Trial details
- NCT number
- NCT04003246
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-03
- Primary completion
- 2022-06-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.